Exelixis EXEL
-
Exelixis' Management Presents at Bank of America Merrill Lynch 2012 Health Care Conference (Transcript)
Exelixis , Inc. ( EXEL ) Bank of America Merrill Lynch 2012 Health Care Conference May 17, 2012, 3:00 p.m. ET Executives Michael M. Morrissey …
-
New Morningstar Analyst Report - Hub Group, Inc.
… million of cash ($1.33 per share) on the balance sheet at the end of 2011--even after spending $83 million to acquire Exel Transportation Services (now Mode) from Deutsche Post DHL in April 2011. The company generates decent free cash flow, averaging …
-
Exelixis' Management Presents at Deutsche Bank Securities Annual Health Care Conference (Transcript)
Exelixis , Inc. ( EXEL ) Deutsche Bank Securities Annual Health ..... late this afternoon. Next, we have Exelixis and presenting we have Charles Butler ..... President of Investor Relations for Exelixis and I’ll be representing the management …
-
New Morningstar Analyst Report for Biogen Idec Inc
… after serving as CEO of development-stage biotech Exelixis EXEL for 14 years. While we see this as an unconventional ..... commercial operations, we think his performance at Exelixis demonstrates a strong understanding of business development …
-
For Dendreon There's A Little Light, But A Lot Of Tunnel
By Stephen Simpson : Volatile biotech Dendreon ( DNDN ) has been a painful lesson for some investors that there's a big difference between good technology and a good stock. The company deserves, and gets, plenty of credit for developing the first-ever cancer vaccine, but serious questions about ...
-
New Morningstar Analyst Report - Exelixis , Inc.
While Exelixis boasts a vast clinical lineup, only ..... pipeline are relatively unknown.Several of Exelixis ' partnership agreements and credit facilities ..... to select an additional candidate from Exelixis ' pool of compounds, thus raising questions …
-
Exelixis's CEO Discusses Q1 2012 Results - Earnings Call Transcript
Exelixis , Inc. ( EXEL ) Q1 2012 Earnings Conference Call May 03, 2012 5:00 PM ET Executives ..... Good day, Ladies and Gentlemen, and welcome to the First Quarter 2012 Exelixis ’ Financial Results Conference Call. My name is Keisha and I'll …
-
Exelixis : Uncovering Value
By David Sobek : While Exelixis ( EXEL ) has 10 partnered programs and a number ..... Cabozantinib (Cabo). In addition, while EXEL is currently filing Cabo for advance ..... multi-billion dollar valuations, EXEL has a market capitalization of only …
-
New Morningstar Analyst Report - Pacer International, Inc.
… services president for one year, but had 25-plus years of experience in transportation and logistics outside Pacer, including at Exel Logistics and Union Pacific. CFO John Hafferty, new in March 2010, served as CFO for international operations of another logistics …
-
Why The Markets Continue To Coalesce Around New Approaches To Treating Cancer
By Brett Korsgaard : The treatment of various forms of cancer is capturing significant media and investor interest. An article featured in last week's The Economist magazine regarding cancer treatment, the well received IPO of Verastem ( VSTM ) and the IPO registration for Stemline Theraeutics have